Endocyte gets upgrade from Piper, shares rise

Endocyte (ECYT +4.2%) rallies in early trading.

Piper has upgraded the shares to Overweight.

Price target is $17, representing upside of 47% from Friday's close.

Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs